- Home
- / Quantum BioPharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Quantum BioPharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$5.4
2024-10-16
Market Capitalization
$66.7 K
2024-10-16
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 257.0K | 15.0K | ||||||
| Cost of goods sold | 2.0M | 1.0M | ||||||
| Gross profit | 88.0K | (1.7M) | (1.0M) | |||||
| Gross profit margin, % | -662.3% | -6780.0% | ||||||
| Operating expense total | 25.2M | 24.8M | 23.3M | 16.2M | 9.2M | 17.1M | 15.4M | 14.8M |
| Depreciation and amortization | 183.0K | 3.4M | 4.5M | 4.0M | 4.5M | 7.1M | 491.0K | 545.0K |
| EBITDA | (25.1M) | (26.5M) | (24.3M) | (16.2M) | (9.2M) | (17.1M) | (15.4M) | (14.8M) |
| EBITDA margin, % | -10300.0% | -162006.7% | ||||||
| EBIT | (25.3M) | (42.1M) | (29.0M) | (21.0M) | (13.8M) | (19.6M) | (15.3M) | (15.1M) |
| EBIT margin, % | -16395.3% | -193540.0% | ||||||
| Interest income | 368.0K | 786.0K | 573.0K | 236.0K | ||||
| Interest expense | 206.0K | 236.0K | 69.0K | 49.0K | 33.0K | 618.0K | ||
| Pre tax profit | (22.7M) | (52.0M) | (31.8M) | (35.3M) | (23.6M) | (18.2M) | (14.9M) | (27.0M) |
| Net Income | (22.7M) | (52.0M) | (31.8M) | (35.3M) | (23.6M) | (18.2M) | (14.9M) | (27.0M) |